Close

Biophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress

Go back to Biophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress
(NASDAQ: BPTS) Delayed: 8.22 -1.48 (15.26%)
Previous Close $9.70    52 Week High
Open $8.24    52 Week Low
Day High $8.96    P/E N/A 
Day Low $8.05    EPS
Volume 18,549